FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology. Described is a group of inventions involving a method of producing a steviol-glycoside compound or a steviol-glycoside composition, a rebaudioside Z2 compound, a sweetener containing the above compound rebaudioside Z2, and use of a sweetener in a food product. In one embodiment, rebaudioside Z2 has a structure represented by the formula:
EFFECT: invention extends the range of steviol glycolides and methods for production thereof for use in food industry.
12 cl, 2 tbl, 4 ex, 14 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E | 2017 |
|
RU2764803C2 |
| HYDROLYSIS OF STEVIOL GLYCOSIDES BY BETA-GLUCOSIDASE | 2018 |
|
RU2775697C2 |
| ABC TRANSPORTERS FOR HIGHLY EFFICIENT PRODUCTION OF REBAUDIOSIDES | 2020 |
|
RU2795855C2 |
| RECOMBINANT CORYNEBACTERIUM GLUTAMICUM FOR EFFICIENT SYNTHESIS OF HIGHLY PURE HYALURONIC ACID AND OLIGOSACCHARIDES THEREOF | 2019 |
|
RU2823305C1 |
| COMPOSITION CONTAINING GLYCOSYLATED STEVIA AND HAVING IMPROVED SWEETNESS QUALITY | 2021 |
|
RU2824097C1 |
| MULTIVALENT PD-L1-BINDING COMPOUNDS FOR TREATING MALIGNANT NEOPLASMS | 2020 |
|
RU2816646C2 |
| ADENOVIRUSES AND METHODS FOR ADENOVIRUS APPLICATION | 2019 |
|
RU2782528C1 |
| SUBUNIT VACCINE FOR TREATING OR PREVENTING RESPIRATORY TRACT INFECTION | 2020 |
|
RU2811991C2 |
| POLYPEPTIDE FOR TREATING PATHOLOGICAL BLOOD CLOTS | 2019 |
|
RU2778566C1 |
| FMDV RECOMBINANT VACCINES AND USE THEREOF | 2015 |
|
RU2745373C2 |
